Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Monroe KM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Okegbe T; GHTASC, Credence Management Solutions LLC, supporting USAID, Office of HIV/AIDS, Washington, DC., Bishop KM; U.S. Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, USA., Rose J; GHTASC, Credence Management Solutions LLC, supporting USAID, Office of HIV/AIDS, Washington, DC., Srivastava M; U.S. Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, USA., Baptiste AJ; GHTASC, Credence Management Solutions LLC, supporting USAID, Office of HIV/AIDS, Washington, DC.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.
Autor:
Shojaei M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Schaefer R; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Schlepckow K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Kunze LH; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Struebing FL; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, University Hospital, LMU Munich, Munich, Germany., Brunner B; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Willem M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Bartos LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Feiten A; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany., Palumbo G; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Arzberger T; Center for Neuropathology and Prion Research, University Hospital, LMU Munich, Munich, Germany.; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Parico GC; Denali Therapeutics Inc, South San Francisco, CA, USA., Xia D; Denali Therapeutics Inc, South San Francisco, CA, USA., Monroe KM; Denali Therapeutics Inc, South San Francisco, CA, USA., Haass C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Lindner S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Publikováno v:
Theranostics [Theranostics] 2024 Sep 30; Vol. 14 (16), pp. 6319-6336. Date of Electronic Publication: 2024 Sep 30 (Print Publication: 2024).
Autor:
Logan T, Simon MJ, Rana A, Cherf GM, Srivastava A, Davis SS, Yoon Low RL, Chiu CL, Fang M, Huang F, Bhalla A, Llapashtica C, Prorok R, Pizzo ME, Calvert MEK, Sun EW, Hsiao-Nakamoto J, Rajendra Y, Lexa KW, Srivastava DB, van Lengerich B, Wang J, Robles-Colmenares Y, Kim DJ, Duque J, Lenser M, Earr TK, Nguyen H, Chau R, Tsogtbaatar B, Ravi R, Skuja LL, Solanoy H, Rosen HJ, Boeve BF, Boxer AL, Heuer HW, Dennis MS, Kariolis MS, Monroe KM, Przybyla L, Sanchez PE, Meisner R, Diaz D, Henne KR, Watts RJ, Henry AG, Gunasekaran K, Astarita G, Suh JH, Lewcock JW, DeVos SL, Di Paolo G
Publikováno v:
Cell [Cell] 2024 Mar 14; Vol. 187 (6), pp. 1565-1566.
Autor:
Monroe KM; Denali Therapeutics Inc., South San Francisco, CA 94080, USA. Electronic address: monroe@dnli.com., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA 94080, USA.
Publikováno v:
Immunity [Immunity] 2023 Aug 08; Vol. 56 (8), pp. 1701-1703.
Autor:
Bosch-Queralt M; Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Cantuti-Castelvetri L; Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Damkou A; Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Schifferer M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Schlepckow K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Alexopoulos I; Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Lütjohann D; Institute for of Clinical Chemistry and Clinical Pharmacology, University of Hospital Bonn, Bonn, Germany., Klose C; Lipotype, Dresden, Germany., Vaculčiaková L; Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany., Masuda T; Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Prinz M; Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany., Monroe KM; Denali Therapeutics Inc., South San Francisco, California, USA., Di Paolo G; Denali Therapeutics Inc., South San Francisco, California, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, California, USA., Haass C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.; Chair of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany., Simons M; Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany. mikael.simons@dzne.de.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. mikael.simons@dzne.de.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany. mikael.simons@dzne.de.
Publikováno v:
Nature metabolism [Nat Metab] 2023 Mar; Vol. 5 (3), pp. 531.
Autor:
van Lengerich B; Denali Therapeutics, Inc., South San Francisco, CA, USA., Zhan L; Denali Therapeutics, Inc., South San Francisco, CA, USA., Xia D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Chan D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Joy D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Park JI; Denali Therapeutics, Inc., South San Francisco, CA, USA., Tatarakis D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Calvert M; Denali Therapeutics, Inc., South San Francisco, CA, USA., Hummel S; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Lianoglou S; Denali Therapeutics, Inc., South San Francisco, CA, USA., Pizzo ME; Denali Therapeutics, Inc., South San Francisco, CA, USA., Prorok R; Denali Therapeutics, Inc., South San Francisco, CA, USA., Thomsen E; Denali Therapeutics, Inc., South San Francisco, CA, USA., Bartos LM; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Beumers P; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Capell A; Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig Maximilians University, Munich, Germany., Davis SS; Denali Therapeutics, Inc., South San Francisco, CA, USA., de Weerd L; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Dugas JC; Denali Therapeutics, Inc., South San Francisco, CA, USA., Duque J; Denali Therapeutics, Inc., South San Francisco, CA, USA., Earr T; Denali Therapeutics, Inc., South San Francisco, CA, USA., Gadkar K; Denali Therapeutics, Inc., South San Francisco, CA, USA., Giese T; Denali Therapeutics, Inc., South San Francisco, CA, USA., Gill A; Denali Therapeutics, Inc., South San Francisco, CA, USA., Gnörich J; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Ha C; Denali Therapeutics, Inc., South San Francisco, CA, USA., Kannuswamy M; Denali Therapeutics, Inc., South San Francisco, CA, USA., Kim DJ; Denali Therapeutics, Inc., South San Francisco, CA, USA., Kunte ST; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Kunze LH; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Lac D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Lechtenberg K; Denali Therapeutics, Inc., South San Francisco, CA, USA., Leung AW; Denali Therapeutics, Inc., South San Francisco, CA, USA., Liang CC; Denali Therapeutics, Inc., South San Francisco, CA, USA., Lopez I; Denali Therapeutics, Inc., South San Francisco, CA, USA., McQuade P; Takeda Pharmaceutical Company, Cambridge, MA, USA., Modi A; Denali Therapeutics, Inc., South San Francisco, CA, USA., Torres VO; Denali Therapeutics, Inc., South San Francisco, CA, USA., Nguyen HN; Denali Therapeutics, Inc., South San Francisco, CA, USA., Pesämaa I; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Graduate School of Systemic Neurosciences, Ludwig Maximilians University Munich, Planegg-Martinsried, Germany., Propson N; Denali Therapeutics, Inc., South San Francisco, CA, USA., Reich M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Graduate School of Systemic Neurosciences, Ludwig Maximilians University Munich, Planegg-Martinsried, Germany., Robles-Colmenares Y; Denali Therapeutics, Inc., South San Francisco, CA, USA., Schlepckow K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Slemann L; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Solanoy H; Denali Therapeutics, Inc., South San Francisco, CA, USA., Suh JH; Denali Therapeutics, Inc., South San Francisco, CA, USA., Thorne RG; Denali Therapeutics, Inc., South San Francisco, CA, USA., Vieira C; Denali Therapeutics, Inc., South San Francisco, CA, USA., Wind-Mark K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany., Xiong K; Denali Therapeutics, Inc., South San Francisco, CA, USA., Zuchero YJY; Denali Therapeutics, Inc., South San Francisco, CA, USA., Diaz D; Denali Therapeutics, Inc., South San Francisco, CA, USA., Dennis MS; Denali Therapeutics, Inc., South San Francisco, CA, USA., Huang F; Denali Therapeutics, Inc., South San Francisco, CA, USA., Scearce-Levie K; Denali Therapeutics, Inc., South San Francisco, CA, USA., Watts RJ; Denali Therapeutics, Inc., South San Francisco, CA, USA., Haass C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Biomedical Center (BMC), Division of Metabolic Biochemistry, Faculty of Medicine, Ludwig Maximilians University, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Lewcock JW; Denali Therapeutics, Inc., South San Francisco, CA, USA., Di Paolo G; Denali Therapeutics, Inc., South San Francisco, CA, USA., Brendel M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilians University, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Sanchez PE; Denali Therapeutics, Inc., South San Francisco, CA, USA. sanchez@dnli.com., Monroe KM; Denali Therapeutics, Inc., South San Francisco, CA, USA. monroe@dnli.com.
Publikováno v:
Nature neuroscience [Nat Neurosci] 2023 Mar; Vol. 26 (3), pp. 416-429. Date of Electronic Publication: 2023 Jan 12.
Autor:
Reifschneider A; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany., Robinson S; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany., van Lengerich B; Denali Therapeutics Inc., South San Francisco, CA, USA., Gnörich J; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Logan T; Denali Therapeutics Inc., South San Francisco, CA, USA., Heindl S; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians-Universität München, Munich, Germany., Vogt MA; ISAR Bioscience GmbH, Planegg, Germany., Weidinger E; Department of Neurology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Riedl L; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany., Wind K; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Zatcepin A; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Pesämaa I; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany., Haberl S; ISAR Bioscience GmbH, Planegg, Germany., Nuscher B; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany., Kleinberger G; ISAR Bioscience GmbH, Planegg, Germany., Klimmt J; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians-Universität München, Munich, Germany., Götzl JK; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany., Liesz A; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians-Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Bürger K; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Levin J; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.; Department of Neurology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Diehl-Schmid J; Department of Neurology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany., Suh J; Denali Therapeutics Inc., South San Francisco, CA, USA., Di Paolo G; Denali Therapeutics Inc., South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA, USA., Monroe KM; Denali Therapeutics Inc., South San Francisco, CA, USA., Paquet D; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians-Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Capell A; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany., Haass C; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Publikováno v:
The EMBO journal [EMBO J] 2022 Feb 15; Vol. 41 (4), pp. e109108. Date of Electronic Publication: 2022 Jan 12.
Autor:
Logan T; Denali Therapeutics, South San Francisco, CA, USA., Simon MJ; Denali Therapeutics, South San Francisco, CA, USA., Rana A; Denali Therapeutics, South San Francisco, CA, USA., Cherf GM; Denali Therapeutics, South San Francisco, CA, USA., Srivastava A; Denali Therapeutics, South San Francisco, CA, USA., Davis SS; Denali Therapeutics, South San Francisco, CA, USA., Low RLY; Denali Therapeutics, South San Francisco, CA, USA., Chiu CL; Denali Therapeutics, South San Francisco, CA, USA., Fang M; Denali Therapeutics, South San Francisco, CA, USA., Huang F; Denali Therapeutics, South San Francisco, CA, USA., Bhalla A; Denali Therapeutics, South San Francisco, CA, USA., Llapashtica C; Denali Therapeutics, South San Francisco, CA, USA., Prorok R; Denali Therapeutics, South San Francisco, CA, USA., Pizzo ME; Denali Therapeutics, South San Francisco, CA, USA., Calvert MEK; Denali Therapeutics, South San Francisco, CA, USA., Sun EW; Denali Therapeutics, South San Francisco, CA, USA., Hsiao-Nakamoto J; Denali Therapeutics, South San Francisco, CA, USA., Rajendra Y; Denali Therapeutics, South San Francisco, CA, USA., Lexa KW; Denali Therapeutics, South San Francisco, CA, USA., Srivastava DB; Denali Therapeutics, South San Francisco, CA, USA., van Lengerich B; Denali Therapeutics, South San Francisco, CA, USA., Wang J; Denali Therapeutics, South San Francisco, CA, USA., Robles-Colmenares Y; Denali Therapeutics, South San Francisco, CA, USA., Kim DJ; Denali Therapeutics, South San Francisco, CA, USA., Duque J; Denali Therapeutics, South San Francisco, CA, USA., Lenser M; Denali Therapeutics, South San Francisco, CA, USA., Earr TK; Denali Therapeutics, South San Francisco, CA, USA., Nguyen H; Denali Therapeutics, South San Francisco, CA, USA., Chau R; Denali Therapeutics, South San Francisco, CA, USA., Tsogtbaatar B; Denali Therapeutics, South San Francisco, CA, USA., Ravi R; Denali Therapeutics, South San Francisco, CA, USA., Skuja LL; Denali Therapeutics, South San Francisco, CA, USA., Solanoy H; Denali Therapeutics, South San Francisco, CA, USA., Rosen HJ; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators., Boeve BF; On behalf of the ALLFTD investigators; Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN, USA., Boxer AL; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators., Heuer HW; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators., Dennis MS; Denali Therapeutics, South San Francisco, CA, USA., Kariolis MS; Denali Therapeutics, South San Francisco, CA, USA., Monroe KM; Denali Therapeutics, South San Francisco, CA, USA., Przybyla L; Denali Therapeutics, South San Francisco, CA, USA., Sanchez PE; Denali Therapeutics, South San Francisco, CA, USA., Meisner R; Denali Therapeutics, South San Francisco, CA, USA., Diaz D; Denali Therapeutics, South San Francisco, CA, USA., Henne KR; Denali Therapeutics, South San Francisco, CA, USA., Watts RJ; Denali Therapeutics, South San Francisco, CA, USA., Henry AG; Denali Therapeutics, South San Francisco, CA, USA., Gunasekaran K; Denali Therapeutics, South San Francisco, CA, USA., Astarita G; Denali Therapeutics, South San Francisco, CA, USA; Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC, USA., Suh JH; Denali Therapeutics, South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics, South San Francisco, CA, USA., DeVos SL; Denali Therapeutics, South San Francisco, CA, USA. Electronic address: devos@dnli.com., Di Paolo G; Denali Therapeutics, South San Francisco, CA, USA. Electronic address: dipaolo@dnli.com.
Publikováno v:
Cell [Cell] 2021 Sep 02; Vol. 184 (18), pp. 4651-4668.e25. Date of Electronic Publication: 2021 Aug 26.
Autor:
Monroe KM; Denali Therapeutics Inc., South San Francisco, CA, USA., Di Paolo G; Denali Therapeutics Inc., South San Francisco, CA, USA. dipaolo@dnli.com.
Publikováno v:
Nature neuroscience [Nat Neurosci] 2021 Apr; Vol. 24 (4), pp. 451-452.